Z-1637-2024 Class II Ongoing
FDA device recall Z-1637-2024 was initiated by Quidel Corporation on Mar 5, 2024 and is designated Class II. Reason for recall: There are two windows on the test device, the control line window and the test results window. The line for the test results window were misaligned. In instances of positive test results, the… The recall status is ongoing. Affected quantity: 31,140 units.
Recall details
- Product Type
- Devices
- Report Date
- May 1, 2024
- Initiation Date
- Mar 5, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 31,140 units
Product description
QUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20, 20 Tests
Reason for recall
There are two windows on the test device, the control line window and the test results window. The line for the test results window were misaligned. In instances of positive test results, the positivite test line may not be visible/ hidden under the cassette of the test device thus potentially leading to a false negative result.
Distribution pattern
US: AK AL AR AZ CA CO CT DC FL GA HI IA ID IL IN KS KY LA MA MD MI MN MO MT NC ND NE NH NJ NV NY OH OK OR PA SC SD TN TX UT VA WA WI WV OUS: United Arab Emirates, Belgium, Canada, Chile, China, Germany, Spain, United Kingdom, Ireland, Italy, South Korea, Lithuania, Qatar
Code information
UDI: 30014613336747/Lot # 162620 and 162748
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1637-2024
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026